SCHEMBL111647

SCHEMBL111647

C=CC(=O)NCCCNC

nearest known ligand 0.62

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ZDHHC20 Q5W0Z9 1/20 0.62
ZDHHC2 Q9UIJ5 1/20 0.62
TSHR P16473 2/20 0.56
MAPK1 P28482 2/20 0.56
ALDH1A1 P00352 2/20 0.56
TDP1 Q9NUW8 1/20 0.56
GAA P10253 1/20 0.44
TGM2 P21980 5/20 0.41
MAPT P10636 1/20 0.39
KMT2A Q03164 3/20 0.36
ATM Q13315 1/20 0.36
KDM4E B2RXH2 3/20 0.35
HIF1A Q16665 1/20 0.34
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL22342052 0.98 ZDHHC20 (0.60) ZDHHC20ZDHHC2TSHRMAPK1ALDH1A1
SCHEMBL113069 0.96 ZDHHC20 (0.68) ZDHHC20ZDHHC2TSHRMAPK1ALDH1A1
SCHEMBL109794 0.94 ZDHHC20 (0.71) ZDHHC20ZDHHC2TSHRMAPK1ALDH1A1
Butane SCHEMBL22264050 0.92 ZDHHC20 (0.65) ZDHHC20ZDHHC2TSHRMAPK1ALDH1A1
SCHEMBL8004880 0.89 ZDHHC20 (0.56) ZDHHC20ZDHHC2TSHRMAPK1ALDH1A1
SCHEMBL1561467 0.89 ZDHHC20 (0.68) ZDHHC20ZDHHC2TSHRMAPK1ALDH1A1
SCHEMBL110584 0.86
SCHEMBL1127677 0.86 ZDHHC20 (0.53) ZDHHC20ZDHHC2TSHRMAPK1ALDH1A1
SCHEMBL12641641 0.85 ZDHHC20 (0.51) ZDHHC20ZDHHC2TSHRMAPK1ALDH1A1
Hydrochloric Acid SCHEMBL27985635 0.84 ALDH1A1 (0.58) ZDHHC20ZDHHC2TSHRMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 187 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250235390-A1 Composition and Process for Treating a Disorder in the Oral Cavity of a Mammal SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2025-07-24 US claimed
EP-3534867-B1 MEDICAL COMPOSITION CONTAINING GUANIDINYL-CONTAINING POLYMER(S) AND CARRAGEENANE(S) SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2025-06-04 EP claimed
EP-4419062-A1 COMPOSITION AND PROCESS FOR TREATING A DISORDER IN THE ORAL CAVITY OF A MAMMAL Solventum Intellectual Properties Company (US) 2024-08-28 EP claimed
US-11766386-B2 Medical composition containing guanidinyl-containing polymer(s) and carrageenane(s) 3M INNOVATIVE PROPERTIES COMPANY (US) 2023-09-26 US claimed
WO-2023067453-A1 COMPOSITION AND PROCESS FOR TREATING A DISORDER IN THE ORAL CAVITY OF A MAMMAL 3M INNOVATIVE PROPERTIES COMPANY (US) 2023-04-27 WO claimed
US-8524111-B2 CMP abrasive slurry for polishing insulation film, polishing method, and semiconductor electronic part polished by the polishing method HITACHI CHEMICAL COMPANY, LTD. (JP) 2013-09-03 US claimed
US-7700540-B2 Hard surface cleaning composition THE CLOROX COMPANY (US) 2010-04-20 US claimed
EP-1593698-B1 The use and preparation of crosslinked polymer particles for inkjet recording materials HEWLETT PACKARD DEVELOPMENT CO (US) 2007-06-13 EP claimed
US-20070099816-A1 Hard Surface Cleaning Composition THE CLOROX COMPANY 2007-05-03 US claimed
EP-0118327-B1 CATIONIC LATICES FROM CONJUGATED DIENES RHONE-POULENC CHIMIE (FR) 1987-04-22 EP claimed
US-12630582-B2 Method for biomaterial purification and kits thereof Life Technologies Corporation (US) 2026-05-19 US disclosed
EP-3870656-B1 ACRYLIC POLYMERS FOR INKJET INK APPLICATIONS CABOT CORP (US) 2026-03-18 EP disclosed
US-20250235390-A1 Composition and Process for Treating a Disorder in the Oral Cavity of a Mammal SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2025-07-24 US disclosed
EP-3534867-B1 MEDICAL COMPOSITION CONTAINING GUANIDINYL-CONTAINING POLYMER(S) AND CARRAGEENANE(S) SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2025-06-04 EP disclosed
EP-3534866-B1 METHOD OF DENTAL RETRACTION WITH COMPOSITION WITH GUANIDINYL-CONTAINING POLYMER SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2025-05-28 EP disclosed
EP-0082056-A1 Cationic acrylamide and rubber modified asphalts OWENS-CORNING FIBERGLAS CORPORATION (US) 1983-06-22 EP disclosed
US-4383081-A Cationic acrylamide chemically modified asphalts OWENS-CORNING FIBERGLAS CORPORATION (US) 1983-05-10 US disclosed
US-4254250-A AMINATED ACRYLONITRILE HOMO- OR COPOLYMERS FOR TREATING SEWAGE SLUDGE, INDUSTRIAL WASTES, SILTY WATER PFIZER INC. (US) 1981-03-03 US disclosed
US-4174152-A Electrochromic devices with polymeric electrolytes AMERICAN CYANAMID COMPANY (US) 1979-11-13 US disclosed
US-3990381-A Hydrophilic polymer coating for underwater structures NATIONAL PATENT DEVELOPMENT CORPORATION (US) 1976-11-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12630582-B2 Method for biomaterial purification and kits thereof CD68, FIBP, BMP2 ZDHHC20 3183/4885ZDHHC2 4088/4885TSHR 2028/4885
US-11766386-B2 Medical composition containing guanidinyl-containing polymer(s) and carrageenane(s) GANC, GMPS, MGAM ZDHHC20 2206/4885ZDHHC2 4025/4885TSHR 4489/4885
US-20250235390-A1 Composition and Process for Treating a Disorder in the Oral Cavity of a Mammal GSDMD, PIGS, GANC ZDHHC20 1883/4885ZDHHC2 3789/4885TSHR 4486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.